Impaired regeneration in LGMD2A supported by increased Pax7 positive satellite cell content and muscle specific microRNA dysregulation by Rosales, Xiomara Q. et al.
Impaired regeneration in LGMD2A supported by increased Pax7
positive satellite cell content and muscle specific microRNA
dysregulation
Xiomara Q. Rosales, M.D.1,2,4, Vinod Malik, Ph.D.1,2, Amita Sneh, PhD.1,2, Lei Chen, MS.1,2,
Sarah Lewis1,2, Janaiah Kota, PhD.1,2, Julie M. Gastier-Foster, Ph.D.3,4, Caroline
Astbury3,4, Rob Pyatt3,4, Shalini Reshmi3,4, Louise R. Rodino-Klapac, PhD.2,4, K. Reed
Clark, PhD.2,4, Jerry R. Mendell, M.D.1,2,4, and Zarife Sahenk, M.D., Ph.D.1,2,3,4
1Neuromuscular Center, The Research Institute at Nationwide Children’s Hospital, Columbus, OH
2Department of Pediatrics and Center for Gene Therapy, The Research Institute at Nationwide
Children’s Hospital, Columbus, OH
3Department of Pathology and Laboratory Medicine, The Research Institute at Nationwide
Children’s Hospital, Columbus, OH
4The Ohio State University, Columbus, OH
Abstract
Introduction—Recent in vitro studies suggest that CAPN3 deficiency leads initially to
accelerated myofiber formation followed by depletion of satellite cells (SC). In normal muscle,
upregulation of miR-1 and miR-206 facilitates transition from proliferating SCs to differentiating
myogenic progenitors.
Methods—We examined the histopathological stages, Pax7 SC content, and muscle specific
microRNA expression in biopsy specimens from well-characterized LGMD 2A patients to gain
insight into disease pathogenesis.
Results—Three distinct stages of pathological changes were identified that represented the
continuum of the dystrophic process from prominent inflammation with necrosis and regeneration
to prominent fibrosis, which correlated with age and disease duration. Pax7-positive SCs were
highest in fibrotic group and correlated with down-regulation of miR-1, miR-133a, and miR-206.
Conclusions—These observations, and other published reports, are consistent with microRNA
dysregulation leading to inability of Pax7-positive SCs to transit from proliferation to
differentiation. This results in impaired regeneration and fibrosis.
Keywords
LGMD2A; Fibrosis; microRNA; Pax; muscle regeneration
INTRODUCTION
The limb-girdle muscular dystrophies (LGMDs) are a clinically and genetically
heterogeneous group of disorders characterized by progressive weakness and wasting of the
proximal limb girdle muscles. LGMD type 2A (calpainopathy) is one of the most common
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forms of LGMD worldwide1–5 and is caused by mutations in the CAPN3 gene, which
encodes a skeletal muscle specific Ca2+ - activated intracellular cysteine protease, calpain-3
(CAPN3)6. As a protease, CAPN3 potentially has a broad range of substrates, and the
anchorage of CAPN3 to the muscle-specific titin protein is thought to serve a stabilizing role
to prevent autolysis.7 A series of studies have demonstrated the role of CAPN3 in sarcomere
assembly, turnover, and maintenance.6,8 It has also been observed in other cellular
compartments, which suggests multiple functions in skeletal muscle.9–12 Of particular
interest, in vitro evidence was presented that CAPN3 plays a role in myogenic
differentiation, more specifically in the maintenance of the pool of reserve satellite cells
(SC) by down-regulating myoD.13 It has been speculated that a calpain deficiency state
would lead to an overall perturbed regeneration response via accelerated myofiber
neoformation, followed by a gradual exhaustion of the SC pool. An important missing piece
of understanding of the pathogenic process in CAPN3 deficiency is muscle fibrosis, a shared
fate with other dystrophies, probably best characterized in Duchenne muscular dystrophy
(DMD). Endomysial fibrosis is an endstage consequence of muscle fiber loss. It is often
explained by a putative failure of muscle fiber regeneration that requires a stepwise process
that includes activation of SCs with transition to proliferation and differentiation, followed
by lateral fusion of myotubes with each other and a subsequent union to surviving muscle
stumps. Recent literature has shown that certain muscle-specific microRNAs (miRs) are
known to play an important post-transcriptional regulatory role in this process.14–17 For
example, miR-1 and miR-206 facilitate SC differentiation by restricting their proliferative
potential. Conversely, down-regulation or inhibition of miRNA-1 and miRNA-206 enhances
SC proliferation and increases Pax7 protein levels in vivo.16–18 This is well-illustrated in
mice that lack miR-206, where muscle regeneration was delayed in response to cardiotoxin
injury due to inefficient SC differentiation.19 Furthermore, deletion of miR-206 from the
mdx model for DMD exacerbated the dystrophic phenotype resulting from failure of SC
differentiation.19 The results from the mdx model demonstrate an inverse relationship
between miR-206 and SC differentiation DMD, a form of dystrophy with extensive fibrosis.
These findings further link miR dysregulation with connective tissue proliferation.16,17,20,21
Another muscle specific microRNA, miR-133a, has been shown to play an essential role in
the maintenance of adult skeletal muscle structure, function, bioenergetics, and myofiber
identity.22
We hypothesized that the severity of LGMD2A is a consequence of muscle fibrosis related
to dysregulation of miR-1, miR-206, and miR-133, muscle specific microRNAs. We first
characterized the muscle biopsy findings from our well characterized LGMD2A population
and identified 3 distinct stages of pathological changes that represent the continuum of the
disease process. A significant increase of Pax7-positive SCs were found in all samples in
comparison with control muscle, similar to those observations in DMD biopsies.20 A Pax7-
positive SC increase correlated with down-regulation of miR-1, miR-133a, and miR-206 in
the fibrotic group. This suggests inefficient regeneration resulting from inability of Pax7-
positive cells to differentiate into competent SCs. The fact that these same microRNAs are
similarly dysregulated in DMD16,21,23 and in X-linked canine muscular dystrophy 17
provides a potential therapeutic target for delaying the onset of skeletal muscle fibrosis not
only in CAPN3 deficiency but other muscular dystrophies as well.
METHODS
Subjects
Forty five patients were evaluated through an NIH supported LGMD characterization study
(NIAMS U54 AR050733-05). Ethics approval was given by the Institutional Review Board
of Ohio State University and Nationwide Children’s Hospital. Written informed consent was
obtained at the time of enrollment. Consistent information was obtained for each patient to
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establish ethnic and geographical origin, family history, consanguinity, age at onset, initial
distribution of symptoms, pattern of muscle involvement, ambulatory status, disease
progression, and serum creatine kinase (CK) levels.
Histopathological Analysis of Muscle Biopsies
Thirty-eight biopsy specimens from a well-characterized cohort of 45 LGMD2A patients
based on DNA testing (see supplementary data; patients 2 and 4 had 2 biopsies, 13 and 14
years apart, respectively) were available for histopathological analysis. These were archived
biopsy specimens obtained between 1994 and 2010. All were mounted in gum tragacanth
and initially frozen in isopentane cooled in liquid nitrogen. A standard battery of stains
included H&E, modified Gomori trichrome, succinic dehydrogenase, NADH
dehydrogenase, and ATPase (pH 4.2, 4.6, and 9.4). Where necessary, considering the age of
the biopsies, some stains were repeated.
The histopathological features of each case were categorized according to the following
criteria: inflammation [(a) none, (b) minimal with small mononuclear cell (MNC)
collections restricted to perivascular regions in the perimysium, or (c) prominent multifocal
areas of MNC collections extending beyond perivascular regions with or without
eosinophils]; necrosis/phagocytosis or regeneration (present in > 10 fibers per section);
lobulated fibers (present in >50% of fibers per section); and fibrosis (grade 0, absent; grade
1, scattered, non-contiguous, focal endomysial connective tissue deposits related to muscle
fiber loss; grade 2, contiguous endomysial connective deposits throughout the muscle
section; grade 3, contiguous endomysial connective deposits throughout the muscle with
fibrosis and fat replacing focal regions of muscle fiber loss; grade 4, diffuse fibro-fatty
changes with marked dropout in the muscle fibers).
Fiber type specific identification of PAx7-positive satellite cell number
Based upon tissue preservation from the archived tissue, 13 biceps muscle biopsy specimens
were available for Pax7 staining that included group 1 (n = 1), group 2 (n =3), and group 3
(n=9). Five of the group 3 biopsies showed lobulated fibers. Three biceps muscle biopsies
from patients with myalgias without histological changes were used as controls. Ten-12 μm
serial cryosections were properly aligned on plus glass slides for cross-sectional fiber
analysis. Pax-7 positive satellite cells were identified with mouse Pax-7 IgG1 antibody (R &
D systems) by an immunohistochemistry protocol of Super Sensitive polymer-HRP
detection kit using i6000™ Automated Staining System from Biogenex®. Briefly,
cryosections were fixed in 2% paraformaldehyde for 10 min at 4°C and incubated in Pax-7
antibody (1:100 dilutions) for 30 min after blocking with peroxide, and Power Block™ for
10 min. Slides were washed 5 times with IHC supersensitive™ wash buffer. Finally, 3, 3′-
Diaminobenzidine (DAB) was used as a substrate with Mayor hematoxylin used as a counter
stain. The adjacent sections were stained for ATPase activity after acid pre-incubation at pH
4.2 followed by a series of dehydration steps to determine the muscle fiber type (in biceps
muscle, type 1 muscle fibers constitute approximately 42 of total fibers).24
From the Pax7-stained slides, randomly selected images were captured at x270 or x540
magnification to allow unambiguous determination of SC localization. Fiber type specific
localization was determined by matching the serial ATPase stained sections at pH 4.2. The
data were used to determine the number of SCs per type 1 and type 2 muscle fibers. The
number of fibers analyzed per case (mean ± SEM) included type 1 = 228.08 ± 50.78 and
type 2 = 80.85 ± 18.48, well above the numbers needed for sufficient estimation of SCs for
each fiber type.25 The overrepresentation of type 1 fibers is related to the type 1 fiber
predominance characteristic of CAPN3 deficiency.
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Identification of muscle specific microRNA expression
For these studies, the same biceps biopsy materials used for PAx7-positive SC analysis were
grouped representing inflammatory (Group 1 and 2; n=3) or fibrotic spectrum [Group 3 with
lobulated fibers (n=3) and Group 3 with non-lobulated fibers (n=3)] and controls (n=3).
Total RNA was isolated from the specimens using a mirVana miRNA isolation kit (Life
Technologies®). Reverse transcription was performed by using a Taqman microRNA
reverse transcription kit (Applied Biosystems®). Quantitative reverse transcription-
polymerase chain reaction (qRT-PCR) for miR-1, miR-206, miR-133a and U6snRNA was
performed using predesigned Taqman primers and probes. Each miRNA expression was
normalized to U6snRNA expression. Expression data were given as means of relative
expression values obtained from 3 samples in conjunction with standard error of means and
presented in a graph format.
Statistical Analyses
For all comparisons with summary statistics indicating practical significant difference, two-
sample t tests were used. Significance level was set at 0.05.
RESULTS
Figure 1 shows the localization of the CAPN3 mutations in our cohort of 45 LGMD2A
patients. Clinical severity was not strictly correlated with disease duration, and although
variability of disease course could not be attributed to the genotype, most of the moderate to
severe phenotypes were associated with nonsense mutations clustered in the proteolytic
domain. See supplementary data for further details of clinical, histopathological and
genotypic features (Tables S1, S2 and S3).
Histopathological studies
Histopathological criteria detailed in Methods, permitted us to place each of the 36 biopsies
into one of the 3 groups (Table S1): Group 1 (n=7), prominent multifocal inflammation with
minimal fibrosis (grade 0–1); Group 2 (n=8), minimal inflammation and grade 1–2 fibrosis;
Group 3 (n=23), no inflammation accompanied by grade 2–4 fibrosis.
Group 1 with minimal or no fibrosis and with multifocal prominent inflammation, necrosis
and regeneration also displayed conspicuous eosinophilic infiltrates in 5 cases (patients 1, 2,
3, 4, and 6) (Figure 2A). The patients with eosinophilic infiltrates were younger (ages of 4 –
25, mean 3.4 ± 7.1 years) at the time the biopsies were performed. The duration of
symptoms (the time between the reported age of onset of clinical symptoms and patient age
at the time of biopsy) varied from 1 to 11 years, mean 4.6 ± 3.7 years. Fibrosis grade was 0
in 3 cases and 1 in 2 cases. Immunoblot analysis showed severely reduced to complete
absence of the CAPN3 protein in all available cases (not shown). Two biopsies [ patients 1
and 3, see Tables S1, S2 and S3] were from patients who had an unusual initial presentation
in the first decade of life consisting of sporadic muscle pain, marked CK elevation (11,000
U/L) and peripheral blood eosinophilia. One of the 5 patients [n=3] is homozygous for a
genetic mutation [c.2306G>A] previously associated with an eosinophilic response.26
Eight cases fit criteria for Group 2. These cases showed minimal inflammation and fiber
necrosis or regeneration occurring scattered or in small clusters and grade 1 or 2 fibrosis
(Figure 2 B, C). These patients represented the intermediate age group (mean age 25.9 ± 9.1
years, symptom duration 10.9 ± 5.6 years). Grade 2 fibrosis was present in 2 patients (n= 8,
13), one of the youngest patients and an older patient in this group with the longest duration
of symptoms. Group 3, representing the oldest group (33.9 ± 11.8 years) with the longest
symptom-duration (17.6 ± 9.3 years) was composed of 23 cases with prominent fibrosis
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(grade 2–4), and no inflammatory infiltrates (Figure 2D–F). Interestingly, in this group
(Table S1), 11 cases (Group 3A) showed a prominent lobulated pattern of cytoarchitectural
change in small and medium fibers (Figure 2E). The mean age (33.7 ± 7.7 years) and the
degree of fibrosis (2.7 ± 0.4) in the lobulated group was similar to those in the remaining 12
patients (Group 3B) who had a non-lobulated pattern (34.1 ± 14.2 and 2.8 ± 1.4
respectively), while the symptom duration was slightly shorter in the lobulated group
without reaching statistical significance (16.5 ± 7.8 vs. 18.5 ± 10.1 years).
Overall, considering the entire cohort there was a good correlation between age, duration of
symptoms and degree of fibrosis (correlation coefficient of 0.604 for the age and 0.583 for
the symptoms duration and fibrosis) (Figures 3A–D).
PAx7-positive satellite cell number and the disease stage in biopsies
Recent in vitro studies have reported that down-regulation of MyoD by CAPN3 promotes
generation of reserve cells in C2C12 myoblasts, suggesting a role for CAPN3 as a potential
new player involved in muscle regeneration by promoting renewal of the SC
compartment.13 In order to explore whether or not CAPN3 mutations have a negative effect
on the SC pool, we quantified the number of Pax7-positive nuclei in type 1 and type 2
muscle fibers in biopsies from 3 distinct histopathological groups representing the entire
spectrum of calpain histopathology. Contrary to the expectation of a gradual decrease of the
SC pool with disease duration (as proposed by Stuelsatz et al) 13, we observed a significant
increase of Pax7-positive SCs in all samples in comparison with control muscle specimens,
similar to the observations in DMD biopsies 20. For the entire cohort, the number of Pax7-
positive cells per muscle fiber was significantly greater than controls (0.192 ± 0.037, n=13
vs. 0.065 ± 0.006, n=3; p=0.006). In addition, the number of SC per type 1 fibers was less
than the number per type 2 fibers (0.171 ± 0.038 vs. 0.275 ± 0.061, n=13; p=0.01), a
reversal of findings in our control specimens. These findings in our controls are in close
agreement with the previously reported normal values using the same SC marker.25 This
fiber type specific change of SC content was maintained in all samples from each group.
Moreover, the number of Pax 7-positive nuclei per muscle fiber showed a positive
correlation with fibrosis grade when 3 histopathological groups were compared (Figure 4A).
Group 3 (n=9) with no inflammation, necrosis, or regeneration and a mean fibrosis grade of
3.1 showed the highest number of SCs per both fiber types in comparison with 1 sample
from group 1 with prominent inflammation, and 3 samples from group 2 with mild
inflammation and grade 1 fibrosis. The biopsy from group 1 with prominent inflammation
and eosinophilia (patient 3 in Figure 1, Tables S1, S2, and S3) had the lowest number of SC
per both type 1 and type 2 fibers accompanied by prominent regeneration (Figure 4B). Fiber
type specific localization of SCs is shown in Figure 4 D and E.
Quantifying muscle fiber types revealed type 1 fiber predominance with increasing age and
duration of disease process in calpainopathy. The percentage of type 1 fibers in group 3 was
significantly higher, 80.9 ± 6.8 % (n=9) compared to group 2 with mild inflammation (50.3
± 6.4, n=3; p=0.03). Within group 3, type 1 fiber predominance was slightly higher in the
subgroup with a lobulated pattern (83.9 ± 8.2, n=5) compared to those without lobulation
(77.0 ± 19.3, n=4) while type 1 fiber SC content was significantly higher in the non-
lobulated group (p=0.03) correlating with higher degree of fibrosis (Figure 3C). For the
entire cohort of group 3, increases in SC number per muscle fiber showed a positive
correlation with the fibrosis grade (r = 0.658). This strong correlation was present only for
type 1 fibers (r = 0.698). These findings clearly show that in calpainopathy, Pax7-positive
SCs are not depleted but instead are increased significantly, correlating with age and disease
progression.
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Muscle specific microRNA expression and PAx7-positive satellite cells in calpainopathy
We analyzed the expression profiles miR-1, miR-206 and miR-133a by qRT-PCR in muscle
biopsies representing different histopathological stages of the dystrophic process in
calpainopathy. We speculated that increased Pax 7-positive nuclei are a morphologic
correlate of decreased miR-1 and miR-206 levels, reflecting inefficient regeneration, and
that type 1 fiber predominance is a manifestation of miR-133a down-regulation. As shown
in Figure 5, miR-1 expression was slightly reduced in the specimens with inflammation,
down to 80% of control levels; however, a significant down-regulation was observed in the
group 3 cohort (0.54 ± 0.10, n=6 vs. 1.00 ± 0.19, n=3; p= 0.039) more notably in the non-
lobulated fibrotic biopsies (38% of control level; −0.6 fold change) similar to those
observations in DMD biopsies and the canine model for DMD.17,23 miR-133a expression
levels showed a similar pattern of changes to miR-1 with the lowest expression in the non-
lobulated fibrotic biopsies from group 3 compared to controls (45% of control level; −0.55
fold change).
miR-206 was previously shown to increase dramatically (more than 10-fold) in regenerating
muscle fibers following cardiotoxin (CTX)-induced injury related to SC proliferation.
Similar findings are seen in mdx mice, a model associated with robust muscle fiber necrosis,
regeneration, and inflammation.17 We observed only a small, 1.6- fold increase of miR-206
expression in the biopsies with inflammation and necrosis/regeneration from younger
patients (Figure. 4). Specimens from group 3 with prominent lobulated fibers also showed a
modest, 2-fold increase in miR-206 expression. However, in group 3, fibrotic biopsies
without lobulated fibers, miR-206 expression was reduced to levels less than control
muscles. Overall, these results suggest that miR-206 is not abundantly expressed in
calpainopathy muscles even in the early stages with inflammation, necrosis, and
regeneration, and declined with age and progression of the dystrophic process.
DISCUSSION
We performed detailed correlative clinical and histopathological studies on a large cohort of
a well-characterized LGMD 2A patient population collected over a 10-year period. In our
cohort of 45 subjects, 46 different CAPN3 gene variances were identified including 12 novel
mutations. A hot spot in exons 4–5 of the catalytic domain II of CAPN3 was demonstrated
with an interesting correlation of clinical severity and nonsense mutations clustered in the
proteolytic domain (see supplementary data).
Analysis of biopsies based on histopathological criteria led to identification of 3 groups of
patients who were clustered by age, symptom duration, and clinical severity. The youngest
patients with the shortest disease duration at the time of biopsy were clustered in group 1
and were characterized by prominent inflammation; the oldest patients with the longest
duration of symptoms were typically in group 3. They had no inflammation but did have
high grade fibrosis. The biopsies from group 2 with minimal inflammation, necrosis, and
regeneration were from patients with intermediate disease severity. This suggests that
groups 1, 2 and 3 represent a continuum of disease in calpainopathy. In our cohort, the age
and symptom duration show a strong correlation with fibrosis grade, supporting the
conclusion that biopsies from patients with longstanding disease are characterized by a
minimally active necrotic process and prominent interstitial fibrosis. Furthermore, we had
the opportunity to examine biopsy materials from patients who were biopsied twice (patients
2 and 4; they were re-biopsied 13 and 14 years later; see supplementary data). We found that
the first biopsy at a younger age had prominent inflammation with eosinophilia, and the
second biopsy showed no inflammation but significant fibrosis, providing direct evidence
for the presence of the 2 ends of the disease spectrum in the same individual.
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In this series, the presence of lobulated, predominantly small and medium fibers was
observed in about one-fourth (11 out of 38) of all biopsies, and it was markedly
overrepresented (48%) in group 3 from patients with a long clinical course. Lobulated fibers
expressed type 1 fiber histochemical markers as previously reported.27 A lobulated pattern
of cytoskeletal change, although nonspecific, is frequently observed in muscle biopsies of
patients with calpainopathy. Gene expression profiles in LGMD 2A muscle biopsies with
lobulated fibers have shown an upregulation of genes that express actin-filament binding
proteins consistent with the structural changes of the intermyofibrillary network.28 Zebra
fish studies show that down-regulation of miR-1 and miR-133 disrupts actin filament
organization during sarcomere assembly.29 Moreover, studies have shown that miR-133a
suppresses the type 1 fiber genetic program, and mice that lack miR-133a have alterations in
the intermyofibrillary network, ring-like fibers, and lobulated-like fibers and interestingly,
fast to slow myofiber conversion.22 As we predicted, miR-133a expression was down-
regulated in biopsies from group 3, where we see type 1 fiber predominance. No previous
studies have demonstrated the relationship between the CAPN3 mutations and a specific
mRNA leading to type 1 fiber predominance.
The analysis of Pax7-positive nuclei in the representative biopsies from each group showed
a significant increase of SCs that correlated with the duration of disease and the degree of
fibrosis. We observed the highest number of Pax7 positive SCs in the group with the highest
grade of fibrosis but no inflammation, necrosis, or regeneration. Our findings are similar to
observations made in DMD muscle biopsies, that, despite increasing fibrosis, Pax7-positive
nuclei per muscle fiber were elevated. This highlights the discrepancy between histological
and cell culture studies.13,20,30–32 Moreover, we see an inverse relationship between the
number of Pax7-positive cells and miR-1, miR-133a and miR-206 expression levels,
indicating that increased Pax 7-positive nuclei is a morphologic correlate of inefficient
regeneration leading to increased fibrosis. In fact, a recent study using a three-dimensional
muscle tissue engineering paradigm provides proof of concept for this direct relationship
between Pax7 expressing cells and miR-1. In that study, the number of Pax7-positive cells
was reduced by transfection with miR-1 compared to microRNA-scrambled controls.33
MicroRNAs are small, non-coding RNA molecules that post-transcriptionally regulate gene
expression in a tissue specific manner. The 3 muscle-specific microRNAs, miR-1, miR-206
and miR-133 have been shown to play important roles in muscle development and
regeneration.14–17 Their potential roles in human myopathic disorders have now begun to
gain interest. In our biopsy specimens, we observed a reduction in miR-1 and miR-133a,
most notable in the fibrotic group similar to DMD biopsies.23 We found miR-206 was
modestly up-regulated (1.6 to 2 fold change) in the inflammatory and lobulated groups, but
down-regulated below control levels in the fibrotic group representing an advanced stage of
the calpainopathy. Moreover, this same pattern of miR-1 and miR-206 reduction is
associated with a significant increase of Pax7-positive SCs in both calpainopathy and DMD
biopsies.20 Taken together, these observations strongly indicate that miR-1 and miR-206
participate in a regulatory manner that allows transition of SCs from proliferation to
differentiation and that the absence of this transition results in an excessive number of Pax7-
positive SCs, impaired myofiber repair/regeneration, and consequent increased fibrosis.
It should be noted that the level of miR-206 up-regulation seen prior to the very late phase of
calpainopathy is modest compared to examples of robust regeneration as seen in wild type
cardiotoxin-induced injury, where miR-206 increases dramatically (more than 10-fold)
within regenerating muscle fibers. This quantitative analysis as well as the results of in situ
hybridization indicates that miR-206 is highly expressed in myotubes newly formed from
SCs in a paradigm with robust regenerative capacity.17 On the other hand, the changes in the
expression levels of these microRNAs in calpainopathy or DMD are more comparable to
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those reported in the canine dystrophy model, which exhibits a more severe clinical
phenotype accompanied by progressive muscle degeneration.17
We believe that our findings are important for illustrating the presence of a similar pattern of
microRNA dysregulation in calpainopathy and DMD, both of which show inefficient
regeneration leading to fibrosis, even though the underlying gene defects are uniquely
different. The link to the understanding of this similar pattern of microRNA dysregulation
associated with markedly disparate gene defects requires further study to unravel a common
feature of the dystrophic process. The importance cannot be overlooked in the evolution of
novel therapeutic strategies.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Localization of the mutations in the Calpain-3 gene. The exons with light blue background
represent the missense mutations; a green background color was used for the frameshift
mutations, purple for deletions, red for stop codon, and yellow for splice site mutations. The
circle shape indicates the patients with a mild phenotype. The exons encircled in a
rectangular shape represent the group with a moderate clinical course, and the diamond
shape for the more severe phenotype. Although the genotype-phenotype correlation is
difficult to interpret in cases of double heterozygosity, most of the moderate to severe
phenotypes correlated with nonsense mutations clustered in the proteolytic domain.
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Figure 2.
A large area of mononuclear cell collections including eosinophils (arrow heads) are seen in
a representative case from group 1 (A). A representative area of grade 1 fibrosis illustrating
pericapillary fibrosis (small arrows) and an area of muscle fiber drop out replaced by
fibrosis (arrow head) from a biopsy classified as group 2 (group 2 represents minimal
inflammation with grade 1–2 fibrosis) is seen in (B) with a large arrow pointing to a small
area of endomysial perivascular inflammation. Diffuse mild endomysial fibrosis (grade 2
fibrosis, arrows) with scarce mononuclear cells is seen in a specimen classified as group 2
(C). Moderately severe diffuse fibrosis, perimysium greater than endomysium (grade 3) is
seen with fatty tissue replacement in some areas of the perimysium (asterisks) in a
representative specimen from group 3 (D). Small and medium size lobulated fibers (arrows
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and inset) are shown in a specimen with diffuse endomysial and perimysial fibrosis from a
group 3A biopsy (E). Diffuse fibrofatty changes (asterisks) with marked drop out in the
muscle fibers from a biopsy in group 3B representing grade 4 fibrosis in (F). Bar = 20 μm
for all panels.
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Figure 3.
Relationship between age and fibrosis (A, B), and duration of symptoms and fibrosis (C, D).
In B, mean age of groups is plotted against mean fibrosis grade; in D, mean duration of
symptoms is plotted against mean fibrosis grade for each histopathological group.
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Figure 4.
Table (A) shows fiber type specific distribution of satellite cells in LGMD2A biopsies
representing histopathological groups, 1, 2 and 3. DD=disease duration, FG=fibrosis grade,
SC=satellite cell. Group 3 with the highest mean FG of 3.1 has the highest number of SCs
(B). SC number in lobulated and non-lobulated biopsies is shown in (C). Non-lobulated
biopsies (n=4) with mean FG of 3.5 displays significantly high SC number per type 1 fibers
(*p=0.035) and per total fibers compared to lobulated biopsies (n=5) with FG of 2.8
(+p=0.026). Serial cross sections of a biceps muscle from a LGMD patient illustrate Pax7
positive SCs (arrows) using immunohistochemistry (D) and fiber types with ATPase at pH
4.2 (E). Fiber type specific localization of SCs (see methods) was determined by matching
the serial ATPase stained sections at pH 4.2. Some fibers with Pax7 positive nuclei marked
as a, b and c in D match with type 1 fibers (darkly stained) in E. II, marks a type 2 fiber with
Pax7 positive SC. Bar = 50 μm.
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Figure 5.
Expression levels of miR-1, miR-133a and miR-206 in biceps muscles of LGMD2A patients
grouped as inflammatory and non-inflammatory (with non-lobulated and lobulated fibers),
and of controls. All expression levels were determined by real time RT-PCR. Results are
presented as mean relative expression ± MSE; n=3. p=0.05 for control vs. lobulated group;
p=0.039 for control (n=3) vs. the entire non-inflammatory cohort (lobulated + non-lobulated,
n=6).
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